Filters close
Newswise: A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease
20-Sep-2022 8:05 AM EDT
A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease
Mount Sinai Health System

Mount Sinai study also shows catching up on sleep doesn’t reverse possible negative effects on cellular level

19-Sep-2022 3:30 PM EDT
New Research Shows Children Exposed to Natural Disasters in the Womb Have Higher Rates of Developmental Psychopathology in a Sex-Specific Manner
Mount Sinai Health System

New data from the longitudinal Stress in Pregnancy Study (SIP Study) have identified earlier onset and higher rates of developmental psychopathology among children whose mothers were pregnant with them during Superstorm Sandy.

16-Sep-2022 4:05 PM EDT
Scientists Identify Unique Breast Cancer Cells That Control Their Ability to Proliferate and Colonize the Lungs
Mount Sinai Health System

Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast cancer cells regulate their own metastases, fuel dissemination from the original tumor site, and determine routes to invade distant organs such as the lungs, according to a study published in Cell Reports in September.

Released: 16-Sep-2022 9:45 AM EDT
Mount Sinai Health System Hospitals Place Among World’s Best in Newsweek/Statista Rankings
Mount Sinai Health System

The Mount Sinai Hospital, Mount Sinai Beth Israel, and Mount Sinai Morningside place among the world's best in Newsweek/Statista rankings.

Released: 14-Sep-2022 12:15 PM EDT
Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals Announce 2022 Winners of CURE-19 Research Pilot Grant
Mount Sinai Health System

Winners will examine impacts of COVID-19 on lung function, maternal and child health outcomes, underrepresented minority youth, and respiratory recovery.

Newswise: Valentin Fuster, MD, PhD, Receives Prestigious Award from Cardiovascular Research Foundation
Released: 14-Sep-2022 7:00 AM EDT
Valentin Fuster, MD, PhD, Receives Prestigious Award from Cardiovascular Research Foundation
Mount Sinai Health System

Mount Sinai Heart leader will be recognized for his exceptional career achievements at the 34th annual conference.

9-Sep-2022 11:00 AM EDT
Researchers Identify Immune Cell That Helps Kill Bladder Cancer Tumors
Mount Sinai Health System

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic option for patients with these types of tumors.

Newswise: Researchers Identify a Potential Path Against Inherited Neurological Disease
Released: 8-Sep-2022 3:05 PM EDT
Researchers Identify a Potential Path Against Inherited Neurological Disease
Mount Sinai Health System

Scientists at the Icahn School of Medicine at Mount Sinai in New York, the National Center for Advancing Translational Sciences (NCATS), and elsewhere have reversed the effects of several life-threatening inherited neurodegenerative diseases called lysosomal storage disorders (LSDs) in patient cells and mice.

Newswise: Mount Sinai Researchers Unravel the Crystal Structure of a Key Enzyme of SARS-CoV-2, Paving the Way for New Antivirals
Released: 8-Sep-2022 12:50 PM EDT
Mount Sinai Researchers Unravel the Crystal Structure of a Key Enzyme of SARS-CoV-2, Paving the Way for New Antivirals
Mount Sinai Health System

Mount Sinai researchers have produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19. The discovery could lead to the design of new antivirals to combat current and future coronaviruses.

Released: 8-Sep-2022 11:15 AM EDT
Mount Sinai Researchers Awarded $2.4 Million Grant From CDC to Support Aging 9/11 Rescue and Recovery Workers
Mount Sinai Health System

As the first responders to the attacks of September 11, 2001, grow older, Mount Sinai’s nationally lauded experts in aging have received a $2.4 million grant from the Centers for Disease Control and Prevention (CDC) to study how best to care for them into old age.

Newswise: New Study Suggests Ketamine May Be an Effective Treatment for Children With ADNP Syndrome
Released: 6-Sep-2022 3:45 PM EDT
New Study Suggests Ketamine May Be an Effective Treatment for Children With ADNP Syndrome
Mount Sinai Health System

Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published online in Human Genetics and Genomic Advances, suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.

Released: 1-Sep-2022 9:55 AM EDT
Mount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma Patients
Mount Sinai Health System

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time—they are meant to enhance the immune system’s destruction of tumor cells.

Newswise: Researchers Find Spaceflight May Be Associated With DNA Mutations and Increased Risk of Developing Heart Disease and Cancer
Released: 31-Aug-2022 10:15 AM EDT
Researchers Find Spaceflight May Be Associated With DNA Mutations and Increased Risk of Developing Heart Disease and Cancer
Mount Sinai Health System

Mount Sinai study could lead to ongoing health monitoring of astronauts to assess possible health risks and prevent disease progression

Newswise: New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
Released: 28-Aug-2022 8:00 AM EDT
New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
Mount Sinai Health System

Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR

Newswise: “Polypill” Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack
Released: 26-Aug-2022 8:30 AM EDT
“Polypill” Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack
Mount Sinai Health System

A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

Newswise: Mount Sinai Awarded $11.6 Million Grant to Launch Comprehensive Center for Surgical Innovation and Expand Mount Sinai BioDesign
Released: 25-Aug-2022 8:00 AM EDT
Mount Sinai Awarded $11.6 Million Grant to Launch Comprehensive Center for Surgical Innovation and Expand Mount Sinai BioDesign
Mount Sinai Health System

In a move that has the potential to change the future of surgery, advance quality care, and bring economic growth to New York City, Mount Sinai Health System announced today the launch of the Comprehensive Center for Surgical Innovation (CCSI).

Released: 22-Aug-2022 1:45 PM EDT
Mount Sinai Health System Receives 2022 LearningElites Award
Mount Sinai Health System

Recognized by annual learning and development benchmarking program for workforce development efforts

Released: 22-Aug-2022 9:45 AM EDT
Mount Sinai Health System Leaders James C. Tsai, Arthur Gianelli, Kristin Myers, and Alan Copperman Named to Crain's 2022 Notable Health Care Leaders List
Mount Sinai Health System

Mount Sinai Health System today announced that Crain’s New York Business Journal has named four of its leaders to its 2022 Notable Health Care Leaders list.

Newswise: Study of More Than 150,000 People Identifies Genes Strongly Linked to Autism and Neurodevelopmental Disorders
17-Aug-2022 12:10 PM EDT
Study of More Than 150,000 People Identifies Genes Strongly Linked to Autism and Neurodevelopmental Disorders
Mount Sinai Health System

Total of 252 genes cited, providing insights on how mutations might result in developmental disorder and potential targets for treatment

Newswise: Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center
Released: 12-Aug-2022 9:50 AM EDT
Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center
Mount Sinai Health System

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

Released: 11-Aug-2022 11:50 AM EDT
Prompt Recognition and Treatment Found Effective for Lung Disease in Patients Who Received New Drug for Advanced Cancer
Mount Sinai Health System

Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August 11, 2022.

Released: 10-Aug-2022 10:55 AM EDT
When Telemedicine Isn’t the Solution
Mount Sinai Health System

In a study published today in the Journal of General Internal Medicine, researchers at the Icahn School of Medicine at Mount Sinai paint a first-of-its-kind nationally representative portrait of the health care needs of older homebound Americans. An estimated 2 million strong and growing, this population has been at once invisible and extremely costly to the health care system. The researchers point to a home-based care model as the solution to better care and a more efficient allocation of health care dollars.

Released: 10-Aug-2022 8:00 AM EDT
Mount Sinai Launches Medical-Legal Program to Address Health-Harming Legal Needs Among Patients
Mount Sinai Health System

The Mount Sinai Health System announced today data from an innovative medical-legal pilot program that proactively identifies and provides free, civil legal services to patients in underserved communities who have unaddressed legal needs to improve their health outcomes.

Released: 9-Aug-2022 1:05 PM EDT
Mount Sinai Awarded Three-Year Grant to Explore Therapeutic Approaches to KRAS Mutant Lung Tumors
Mount Sinai Health System

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer® (SU2C) to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

Released: 9-Aug-2022 8:05 AM EDT
Icahn School of Medicine at Mount Sinai Announces Biomedical Laureates to Address Health Disparities in Environmental Health, Cancer, and Emergency Medicine
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai announced today the appointment of three new Laureates as part of its Biomedical Laureates Program, furthering its institutional commitment to broadening diversity and mentorship opportunities.

Released: 5-Aug-2022 2:05 PM EDT
Researchers Gain Insights Into the Genetic and Molecular Machinery that Predisposes Individuals to Alzheimer’s Disease
Mount Sinai Health System

Mount Sinai researchers have achieved an unprecedented understanding of the genetic and molecular machinery in human microglia—immune cells that reside in the brain—that could provide valuable insights into how they contribute to the development and progression of Alzheimer’s disease (AD). The team’s findings were published in Nature Genetics.

Released: 4-Aug-2022 11:00 AM EDT
Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Mount Sinai Health System

A team of researchers at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells)—cells in the pancreas that produce and distribute insulin.

Released: 3-Aug-2022 10:05 AM EDT
Jack Martin Fund Gives $3.5 Million to Mount Sinai Kravis Children’s Hospital to Establish State-of-the-Art Child and Adolescent Imaging Center
Mount Sinai Health System

The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide cutting-edge care and support to children with cancer through a new $3.5 million gift to The Mount Sinai Hospital to establish the Jack Martin Fund Child and Adolescent Imaging Center at Mount Sinai Kravis Children’s Hospital.

Released: 2-Aug-2022 10:05 AM EDT
Mount Sinai Health System Partners with Contessa to Create Mount Sinai at Home, a Home-Based Care Continuum
Mount Sinai Health System

Mount Sinai Health System and Contessa, the leading comprehensive home-based care provider, announced the extension of their partnership combining Mount Sinai South Nassau’s home health agency into their existing joint venture. The new combination offers a full continuum of home-based care that includes home health, hospitalization at home, rehabilitation at home (in lieu of care at a skilled nursing facility) and palliative care at home. The home health agency will be called Mount Sinai at Home.

Released: 2-Aug-2022 8:30 AM EDT
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Mount Sinai Health System

Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker

Released: 2-Aug-2022 8:00 AM EDT
Three Mount Sinai Nursing Leaders to Be Inducted as Fellows in the American Academy of Nursing
Mount Sinai Health System

Three Mount Sinai nurse leaders have been selected to be Fellows of the American Academy of Nursing (AAN) in the 2022 Class of Fellows.

Released: 1-Aug-2022 11:05 AM EDT
In a Race to Cure Childhood Brain Cancer, Leading Experts Unveil the Mount Sinai Children’s Brain and Spinal Tumor Center
Mount Sinai Health System

In a race against time to cure childhood brain cancer, the leading cause of cancer deaths among children, Mount Sinai Kravis Children’s Hospital is forming the Mount Sinai Children’s Brain and Spinal Tumor Center.

25-Jul-2022 5:55 PM EDT
The Mount Sinai Hospital Ranked Among Top Hospitals in the Nation for the Seventh Year in a Row by U.S. News & World Report
Mount Sinai Health System

The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the third consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the seventh year in a row.

Newswise: Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients
20-Jul-2022 8:30 AM EDT
Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients
Mount Sinai Health System

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

Released: 21-Jul-2022 2:20 PM EDT
Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Researchers Report
Mount Sinai Health System

Treating liver cancer tumors to shrink them in order to allow the patient to qualify for a liver transplant leads to excellent 10-year post-transplant outcomes, according to new Mount Sinai research published in JAMA Surgery. The results validate current national policies around transplant eligibility.

Released: 12-Jul-2022 9:00 AM EDT
Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Mount Sinai Health System

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

Newswise: Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Young Adult Populations in Underserved Communities
6-Jul-2022 8:30 AM EDT
Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Young Adult Populations in Underserved Communities
Mount Sinai Health System

A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.

Newswise: Stress Testing Can Help Determine Which Patients Are Likely to Benefit From Heart Procedures to Improve Survival
5-Jul-2022 1:05 PM EDT
Stress Testing Can Help Determine Which Patients Are Likely to Benefit From Heart Procedures to Improve Survival
Mount Sinai Health System

Mount Sinai study can help guide proper treatment course for patients depending on heart function and severity of heart damage

1-Jul-2022 1:05 PM EDT
Prenatal Exposure to Chemicals in Consumer and Industrial Products Is Associated With Rising Liver Disease in Children
Mount Sinai Health System

The growing incidence of a potentially cancer-causing liver disease in children is associated with prenatal exposure to several endocrine-disrupting chemicals, Mount Sinai researchers report.

Released: 6-Jul-2022 8:05 AM EDT
Researchers Discover Mechanisms of Drug-Resistant Fungal Infection in Transplant Patient
Mount Sinai Health System

Experts Encourage Rapid Genomic Screenings and Development of New Therapeutics for Drug-Resistant Pathogens to Address Emerging Global Health Concern

23-Jun-2022 12:15 PM EDT
Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say
Mount Sinai Health System

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.

Released: 27-Jun-2022 8:00 AM EDT
Study Finds Untreated Sleep Apnea May Increase Risk for Neurodegenerative Disease, PAP Therapies Crucial in Treating the Sleep Condition
Mount Sinai Health System

Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer's disease biomarkers from blood.

Newswise: Specific Environmental Exposures may Help Predict Increased Risk of Death from Cardiovascular Disease
21-Jun-2022 10:00 AM EDT
Specific Environmental Exposures may Help Predict Increased Risk of Death from Cardiovascular Disease
Mount Sinai Health System

A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 percent.



close
0.25647